Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the IONIC t...

por Sharma, Kavi, Berry, Lisa, Vryonis, Evangelos, Ali, Asad, Lara, Beatriz, Noufaily, Angela, Parsons, Nicholas, Bradley, Christopher, Haley, Becky, Tabuso, Maria, Arasaradnam, Ramesh P
Publicado 2022